Tech Company Financing Transactions
Q Bio Funding Round
Andreessen Horowitz and private investors invested in a $40 million Series B funding round for Q Bio. The round was announced on 2/21/2020.
Transaction Overview
Company Name
Announced On
2/21/2020
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
Andreessen Horowitz (Lead Investor) (Vijay Pande)
Proceeds Purpose
This latest round of funding will allow Q Bio to continue to improve its proprietary platform and technology to make their preventive health services faster, better and more affordable for all.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
410 Brewster Ave.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Non-invasively measure and quantify more about the human body, faster and cheaper. Give individuals access to and control over information about their health and bodies. Provide individuals and their clinicians intelligent tools to help them quickly understand the most important changes in their bodies and what those changes mean for their current and future health risks.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Kaditz
Chief Medical Officer
Garry Choy
Chief Operating Officer
Clarissa Shen
Founder
Michael Snyder
Vice President
Athanasios Polimeridis
Vice President
Thomas Witzel
Browse more venture capital transactions:
Prev: 2/21/2020: Volocopter venture capital transaction
Next: 2/21/2020: EnClear Therapies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs